The Axl receptor tyrosine kinase is a transforming oncogene in NIH3T3 cells. In order to de®ne structural requirements of the Axl receptor necessary for transformation we passaged recombinant retroviruses carrying the axl cDNA in NIH3T3 cells, generating randomly mutated axl variants. Using this strategy, we have isolated three axl viral strains (1B1, SV8, and FFa4) that show augmented 3T3 cell transforming capacity associated with elevated p140
Introduction
The Axl/Ufo receptor is the founding member of a family of receptor tyrosine kinases (RTKs) characterized by their unique extracellular composition consisting of immunglobulin-like and ®bronectin type Ill-like domains. This domain architecture is also found in adhesion molecules of the cadherin-and immunoglobulin superfamily and in receptor protein tyrosine phosphatases such as LAR or PTPm and PTPk (Edelmann and Crossin, 1991; Fischer et al., 1991; Charbonneau and Tonks, 1992) . In addition, unique sequences within the kinase domain distinguish axl and its related kinases (sky and mer) from other type I RTKs. These structural ®ndings suggest that Axl family members may mediate both cell adhesion and intracellular signaling (Bellosta et al., 1995; Pulido et al., 1992) .
Axl's role in normal and malignant cell biology has not been completely elucidated but appears to be complex. We and others have found that Axl is a transforming gene that is overexpressed in some metastatic epithelial cancers (Quong et al., 1994; Craven et al., 1995) and is overexpressed in approximately 25% of primary breast cancers (Attar and Liu, manuscript in preparation). All members of the Axl/ Ufo family can transform NIH3T3 cells. sky and mer/ eyk are rendered transforming by 5' truncation or substitution leading to an RTK with an altered extracellular domain (Taylor et al., 1995; Jia et al., 1992) . When transfected, axl transforms by overexpression with no activating mutations reported. The transforming activity, however, is weak in that transfection followed by short term passaging of 3T3 cells was necessary to uncover the transforming activity. Using a chimeric receptor construct containing the EGFR extracellular and transmembrane domains and Axl kinase domain (called EAK for EGFR-Axl-Kinase) introduced into the murine myeloid cell line 32D, we found that prolonged stimulation of the kinase by the foster ligand, EGF, resulted in the generation of factor independent 32D sublines able to grow in the absence of IL-3. Factor independent growth is a hallmark of transformation in this cell system and appeared to be correlated with dramatic overexpression of the EAK chimeric receptor leading to ligand independent signaling (McCloskey et al., 1994) . Thus, in several systems, Axl is capable of cellular transformation through constitutive activation of its kinase function achieved through receptor overexpression. The same results have been seen in other type I RTKs: HER-2/neu is primarily transforming through ampli®cation and overexpression, though amino acid substitutions in the transmembrane domain will activate the RTK by enhancing receptor dimerization (Bargmann et al., 1986; Slamon et al., 1989) .
Surprisingly, however, the Axl ligand, GAS-6, is only a weak mitogen in a restricted range of tissue such as 3T3, Schwann, and vascular smooth muscle cells (Goruppi et al., 1996; Gasic et al., 1992; Li et al., 1996) and appears to play a greater role in modulating cellular responses to other factors such as thrombin and angiotensin II (Nakano et al., 1995) . That a ligand shows little mitogenic activity when interacting with a RTK with transforming function has been seen in the Eph receptor tyrosine kinase family (Brambilla et al., 1995) . Inducing mitogenesis is therefore only a limited aspect of RTK signaling as Eph family members demonstrate the ability to mediate fasciculation and collapse of axons of the retinal ganglion and thereby regulate targeting of axons.
Developmentally, Axl is temporally expressed in embryonic mesenchymal cells immediately prior to organogenesis (Sadler and Liu, manuscript in preparation) . Recently, we have determined that Axl can eectively mediate cell-cell adhesion in a GAS-6 dependent manner (McCloskey and Liu, in press) . Taken together, these results raise the possibility that Axl is potentially involved in cell recruitment during embryogenesis through its adhesion and signaling functions.
Given the complexity of Axl biology, we sought to identify the structural requirements for Axl kinase activation using 3T3 transformation as the biological assay. Our screening strategy employed the error-prone nature of the reverse transcriptase during the retroviral life cycle to generate functionally transforming mutants of axl; the in vivo forward point mutation rate of the retroviral reverse transcriptase varies between 10 75 and 10 73 per base per replication cycle, whereas insertions and deletions are less common (1610 77 /b/replication cycle) (Monk et al., 1992; Dougherty and Temin, 1988) . A similar approach of randomly mutating genetic sequences through retroviral replication was used for the derivation of an oncogenic variant of the erythropoietin (EPO) receptor (Yoshimura et al., 1990) . After selection for retroviral strains containing viral particles with an augmented ability to transform 3T3 cells, we analysed the structural correlates to the heightened transforming action. We found that though overexpression remained the most potent means to render Axl transforming, C-terminal truncation resulting in the formation of a chimeric receptor comprised of appended sequences from the 3' untranslated region (UTR) could also activate the Axl kinase. Furthermore, we found that NR6 and 32D cells were resistant to Axl transformation when compared to 3T3 cells. This resistance appeared to be associated with the absence of a pp190 phosphoprotein found in passaged 3T3 cells and could be overcome by a 30 ± 60-fold further increase in surface Axl expression.
Taken together, our results suggest that Axl's transforming activity is dependent not only on structural changes within the Axl protein, but also on the level of surface p140
Axl expression in particular cellular contexts.
Results

Generation of transforming axl mutants
In order to develop infectious axl-retroviruses, the wild-type ax16-2 cDNA was cloned into the retroviral expression vector pLXSN (thereafter called pLaxlSN) and subsequently transfected into NIH3T3 ®broblasts. After G418 selection, axl-transfected 3T3 cells were infected with conditioned media (CM) containing the wild-type Moloney Murine Leukernia Virus (MoMLV) as described in Materials and methods. MoMLV thus served as the helper virus in packaging pLaxlSN transcripts. The generation of replication competent retroviruses in the CM of these transduced 3T3 cells was con®rmed by the presence of reverse transcriptase activity as previously described (data not shown) (Fan et al., 1988) .
Conditioned media derived from MoMLV infected pLaxlSN cells was then tested for the presence of axlcontaining retroviruses by Western blot analysis of the human p140
Axl protein in newly infected 3T3 cells. Axl expression could be found only after infection with supernatant obtained from MoMLV-pLaxlSN cells. Despite detectable levels of Axl expression, MoMLVpLaxlSN infected cells were not transformed (data not shown). This is in accordance with our earlier transfection results using the pLaxlSN construct showing that axl is a weak oncogene requiring cell passage for transformation to become manifest (O'Bryan et al., 1991) .
In order to generate axl-containing viral strains with augmented transforming activity, we serially passaged the MuLV-pLaxlSN viral supernatant in naive 3T3 cells. Initial infections were performed using the MuLV-pLaxlSN virus stock, and cells were selected in G418 for incorporation of the viral construct. Conditioned media from these G418 resistant populations was then used to further infect naive 3T3 cells. After a total of three rounds of viral passage, a viral strain emerged capable of transforming 3T3 cells within 12 days post infection.
Seven transformed foci from this infection were clonally expanded and found to exhibit dierent levels of p140
Axl overexpression as seen by Western analysis employing a C-terminal anti-Axl antibody (Figure 1 ). Of these, three transformed clones showing the highest level of Axl tyrosine phosphorylation (SV8, 1B1 and FFa) were isolated for further study. Each was found to release axl-containing virions capable of limited transformation in an NIH3T3 cell focus formation assay; transformation was observed within 12 days of infection, with approximately 20 foci per plate. This suggested that within each viral strain, a subpopulation existed with higher transforming potential. To select for these transforming retroviral sublines, CM from SV8, 1B1 and FFa infected cells were subjected to further viral passage. We screened for new viral phenotypes by systematically assessing the extent of and time required for focus formation. In addition, Axl expression and tyrosine phosphorylation were analysed after every completed cycle of viral passage. Interestingly, after the fourth passage of FFa-CM, the FFa virus (termed FFa4) transformed an entire 100 mm dish of NIH3T3 cells within a period of 6 days. By contrast, comparable passage of the 1B1 and SV8 viral strains resulted in viruses that still could induce only 30 and 26 foci per plate, respectively. This dierence was not due to a greater amount of virions in the FFa-CM since quantitation of the viral concentration as assessed by the number of G418 resistant colonies after limiting dilution showed comparable levels between the FFa, SV8, and 1B1 viral sublines. Furthermore, the transforming potential resided in the recombinant virus and was not due to proviral insertion since subsequent passages of the FFa4 viral sublines (FFa5 and FFa6) demonstrated an equally high transforming capacity.
Biochemical characterization of transforming axl mutants
Western blot analysis was used to characterize the 3T3 cells transformed by the three viral sublines with respect to Axl expression and tyrosine phosphorylation. Immunoblotting with an antiphosphotyrosine antibody (a-pTyr) demonstrated highly phosphorylated proteins at 120 and 140 kD consistent with the human Axl protein found in 1B1, SV8 and FFa4 strains but not in parental 3T3 cells. When the same lysates were analysed using a polyclonal antibody speci®c for the Axl carboxyterminus (17-4), cell lines 1B1 and SV8 demonstrated high levels of Axl expression. However, the same antibody failed to detect the presence of Axl in FFa4 cell lysates either by immunoblotting or immunoprecipitation (Figure 2 ). To further investigate these ®ndings, lysates were also blotted with an NH 2 -terminal Axl antibody. This, in contrast, revealed signi®cant Axl expression in all cell lines, including FFa4 (Figure 2a ). Taken together, these data indicated that the most transforming virus, FFa4, may contain alterations which alter the carboxyl terminus of Axl, thus rendering it undetectable by the 17-4 antibody.
Sequence analysis of the axl transforming mutants
In order to determine the structural basis for Axl transformation, the three derived axl proviruses (1B1, SV8 and FFa4) were subcloned and subjected to sequence analysis. Using axl primers spanning approximately 500 ± 600 base pairs, various segments of the entire FFa4-axl cDNA were ampli®ed from the FFa4 infected 3T3 cells. Interestingly, using a primer pair (PJA18 and PJA20) that ampli®es the 3' portion of the axl cDNA between bp 2534 (end of codon 792) and bp 3023 (in the 3' UTR), we detected two fragments with distinct mobilities when resolved on a 1% agarose gel. One PCR fragment was of the expected 489 bp length and the other, much stronger band, measured 294 bps. This 294 bp band was not seen using DNA from other axl transduced 3T3 cells as template. These observations suggested that FFa4 CM contains two distinct viral subclones: one missing sequences in the 3' domain of the axl cDNA (which we designate FFa4short), and the other carrying an axl cDNA of the appropriate length.
Sequence analysis of the smaller fragment revealed a 195 bp deletion in the 3' end of the axl cDNA from bp 2706 to bp 2900, removing 138 bps of the coding region. Because the normal axl stop codon is involved in this deletion, FFa4short would be predicted to generate a read through transcript adding 210 bps from the wild-type axl 3' UTR to the truncated FFa4 sequence ( Figure 3a , b and c). Thus, the FFa4short virus expresses an Axl protein that consists of the ®rst 849 amino acids of the native protein followed by 69 amino acid residues derived from sequences from the 3' UTR before terminating at a new stop codon at bp 3110 ( Figure 3d ). This con®rms our earlier ®ndings suggesting the absence of C-terminal Axl peptides in FFa4, since the anti-Axl antibody 17-4 recognizes epitopes located within the deleted 138 bp 3' region. We used the University of Wisconsin Sequence Analysis Software Package by Genetics Computer, Inc. (GCG) and determined that the new C-terminus does not contain known protein patterns de®ned in the PROSITE Dictionary of Protein Sites and Patterns (MOTIFS). In addition, no homology to known proteins in the PIR and SwissProt protein databases was seen using the BLAST network service at the National Center for Biotechnology Information (NCBI) (Altschul et al., 1990) .
Sequence analysis of the 1B1 and SV8 proviruses revealed no coding changes. However, both contained a silent mutation at bp 1961 (T?C) shared by all viral mutants sequenced, including FFa4. A further silent mutation was identi®ed in SV8 at bp 1724 (G?A). Because both 1B1 and SV8 were found to contain only silent mutations which preserved the wild-type Axl amino acid sequence, we postulate that overexpression of the receptor, possibly through activating mutations in the long terminal repeat (LTR), is the mechanism responsible for transformation by these two viral strains. This mechanism has been previously documented in other systems (Grez et al., 1991) .
The presence of these silent mutations also de®ned the genetic lineage of the three viral strains: all appeared to be clonally derived from a common progenitor retrovirus harboring the 1961 (T?C) variant. The SV8 and the FFa4 viruses are further clonal expansions with their individual sequence signatures ( Figure 8 ).
Axl's carboxyl terminus is important in regulating Axl function
Because the FFa4short virus demonstrated both the loss of 45 amino acids at the Axl carboxyl terminus (amino acids 850 ± 894) and the gain of 69 amino acids derived from previously untranslated sequence, we sought to specify the structural alterations responsible for the FFa4short associated transformation. Point mutations and deletions of the C-terminal domains of many tyrosine kinases lead to enzymatic activation (see Discussion and References therein). Moreover, a tyrosine at amino acid 866 which is deleted in the Axl protein FFa4short is highly conserved among the Axl family of kinases, and may be functionally homologous to the negatively regulating tyrosines on src (aa 527) and EGFR (aa 1173, 1148, 1068) .
To ascertain the importance of carboxyl-terminal deletions in the activation of Axl's transforming function, truncation mutants were generated by introducing premature stop codons at bp 2717, corresponding to aa854 (axl854) and at bp 2789 (axl878) as illustrated in Figure 4B . The truncation mutant axl878 still contained the conserved tyrosine at aa 866 and therefore was a test of the importance of this C-terminal tyrosine residue. Furthermore, to speci®cally address the possibility that this tyrosine residue may play a role in the negative regulation of Axl function, the tyrosine at codon 866 was replaced by phenylalanine to generate the axl mutant Y866F. axl854, axl878, Y866F and the FFa4short axl cDNAs were subcloned into the mammalian retroviral expression vector pLXSN and transfected into GP+E86, an ecotropic retroviral packaging cell line. Conditioned media derived from these transfected cells was used to infect NIH3T3 ®broblasts, which were then scored for transformation.
We observed that while pLFFa4shortSN transformed NIH3T3 cells to the same extent as the original viral strain FFa4short, pLXSN, pLaxlSN, pLaxl854SN, pLaxl878SN and pLY866FSN transduced cells did not undergo cellular transformation ( Figure 4A ). Figure 4A (c) shows that pLFFa4shortSN infected 3T3 ®broblasts exhibited a transformed phenotype characterized by lack of contact inhibition, multilayer growth and spindleshaped morphology. Because neither axl854, axl878 nor Y866F could transform ®broblasts in a similar fashion to FFa4short, we concluded that the exchange of amino acids resulting from the read-through of 3' UTR sequences rather than carboxy-terminal truncation serves as the critical transforming feature of the FFa4short mutant. Western blot analysis revealed that pLFFa4shortSN infected cells expressed higher levels of p140
Axl and its phosphorylated forms than the cells transduced by the other axl mutants ( Figure 4C ). These data show that Axl truncation alone is insucient to induce cellular transformation whereas the presence of appended sequences derived from the 3' UTR appear to activate Axl's transforming potential. Moreover, the possibility is raised that overexpression contributes to FFa4short-induced transformation.
Axl transformation is cell line speci®c
Having developed a series of recombinant viruses capable of eciently transforming NIH3T3 cells, we Figure 3 Genetic map of the carboxy terminal deletion mutation in FFa4short. Using the axl primer pair PJA18 (5'-CGGCCAAGTTTTACAGAGCT-3') and PJA20 (5'-CAAGGT-GATGCTACTGCACA-3') a 294 bp fragment was ampli®ed from FFa4 genomic DNA and sequenced. Sequence analysis revealed a 195 bp deletion in the 3' end of the axl cDNA resulting in the abrogation of 138 bp of the coding region including the native stop codon. Schematic illustration of (a) the full length Axl structure, (b) the 3' portion of the wild type axl cDNA, (c) the 3' deletion of 195 bp of the FFa4short cDNA resulting in the addition of 210 bp from the wild-type axl 3' UTR to the coding sequence of FFa4short, and (d) the modi®ed amino acid sequence of the FFa4short protein is depicted in boldface. IGL: Immunoglobulin-like domain; FNIII: Fibronectin type III domain; TM: Transmembrane region; TK: Tyrosine kinase domain; C-terminus: Carboxy terminus region; UTR: untranslated region wished to determine whether this transforming potential could be assessed in other cell systems. To this end, we infected the IL-3 dependent myeloid precursor cell line 32D (gift of Dr J Pierce) with FFa4, 1B1 and SV8 viral stocks giving rise to 32D cell sublines: FFa4.1, harboring mainly the truncated axl variant (not shown), and 1B1 and SV8, expressing the respective axl cDNAs. Transformation was scored as the ability of infected 32D cells to grow in a factor independent manner (McCloskey et al., 1994) .
Intriguingly, none of the axl viruses transformed 32D cells, despite the presence of comparable or greater surface levels of Axl than in 3T3 cells as assessed by¯ow cytometry and con®rmed by Western blot analysis (Figures 5a, b and 6a) . The dierence, however, was that whereas the human Axl expressed in transduced 3T3 cells was tyrosine phosphorylated, there was no detectable Axl phosphorylation on tyrosine in the infected 32D cells (Figure 5a and b) . To prove that the axltransduced 32D cells harbored a transforming axl virus, supernatants from infected 32D cells were applied to naive 3T3 cells which were then scored for transformation. All 32D supernatants eciently transformed 3T3 cells within 10 ± 12 days, showing that passage through 32D cells did not aect the transforming capability of the axl viruses.
The observation that 32D cells cannot be transformed when expressing comparable levels of Axl oncoprotein to Axl-transformed 3T3 cells indicated that cell lines may vary in their requirements for transformation by Axl. Alternatively, the biology of these transforming viruses may dier in cells grown in suspension (e.g. 32D cells) compared to adherent cells (i.e. 3T3). To test this latter possibility, the ®broblast cell line NR-6, a modi®ed NIH3T3 cell line devoid of EGF receptors, was similarly infected with the FFa4 and SV8 viruses and observed for phenotypic changes. Following G418 selection, the infected NR-6 cells appeared morphologically normal despite signi®cant Axl expression detectable on Western blot analysis (Figure 5c ). Flow cytometry demonstrated comparable levels of surface Axl expression in the axl-transduced but untransformed NR-6 cells and in the axl virus transformed 3T3 cell lines (data not shown). Again, like the 32D cells, the axl-infected NR-6 cell lysate failed to demonstrate tyrosine phosphorylation of the transduced Axl protein (Figure 5c ).
We were intrigued by the inability of the FFa4 and SV8 viral strains to transform 32D and NR-6 cells and asked whether we could generate axl viruses that could transform these apparently resistant cells. To this end, we continued passaging the FFa4.1 and SV8/FFa4.1 viruses in naive 32D and NR6 cells and observed for the emergence of IL-3 independent cell lines (32D) or for transformed foci (NR6). Even after four viral passages, we were not able to induce 32D or NR6 cell transformation under these conditions. Thus, 32D and NR6 cells appear to be relatively resistant to transformation by Axl as compared to 3T3 cells.
In investigating the mechanism of this resistance, we examined the phosphoprotein pro®les of axl-transduced 3T3, NR6 and 32D cells. As mentioned before, whereas p140
Axl is phosphorylated on tyrosine in transformed 3T3 cells, it is present but not phosphorylated in transduced NR6 and 32D cells (Figure 5a These results demonstrate that transformation by FFa4short is due to gain of sequences derived from the 3' UTR rather than truncation of the Axl C-terminus NR6 or 32D cells (Figure 5a ). This raises the possibility that pp190 is involved in the relative susceptibility to Axl transformation in NIH3T3 ®broblasts. To elucidate the nature of pp190, we assessed several candidate molecules. 3T3 cells express low but detectable amounts of EGFR; by contrast, 32D and NR6 cells do not express EGFR. However, by immunoprecipitation and Western blot analysis using combinations of anti-phosphotyrosine and antiAxl antibodies, we determined that the pp190 is not EGFR (data not shown). Moreover, preclearing the 3T3-Axl transformed cell lysates by an anti-EGFR antibody (1382; gift of Dr S Earp) did not reduce the intensity of pp190, further con®rming this conclusion. Using the same approach, we then determined that the pp190 is neither PDGFR, IRS-1 nor IRS-2 (antibodies gift of Dr L Wang). Thus the identity of the pp190 remains unclear. 
Suprathreshold expression of the axl gene is associated with 32D cell transformation
Though we were not able to generate an axl viral strain that could transform 32D cells, we found that following 7 ± 8 rounds of cellular passage of FFa4.1 32D cells, a clone emerged which was adherent to plastic and could grow in the absence of IL-3, both characteristics of transformation in the 32D cell system. We called this cell line FFa4.1-FI (FI for factor independent). Western blot analysis and immunoprecipitations were used to characterize FFa4.1-FI with respect to Axl expression and tyrosine phosphorylation (Figure 7) . Whereas the untransformed FFa4.1 32D cells previously demonstrated only minimal p140 Axl phosphorylation, the FFa4.1-FI cells expressed much higher levels of p140
Axl which was now tyrosine phosphorylated. To show that the 32D cell transformation was not restricted to this viral strain, we continued to passage the untransformed SV8 infected 32D cells and isolated a subclone that was adherent to plastic and able to grow in IL-3 depleted media in a similar manner to FFa4.1-FI cells. The resulting cell line, SV8/4.1-FI, also demonstrated elevated p140
Axl expression which again was tyrosine phosphorylated (Figure 7) . We sequenced the proviruses of FFa4.1-FI and SV8/4.1-FI using the identical approach as described previously and found that both maintained the wild-type Axl amino acid sequence, indicating that dramatic overexpression of the normal Axl receptor could drive factor independent growth in 32D cells. Western blot and PCR analyses revealed that FFa4.1-FI is an out growth of the 32D cell subclone that harbors the intact axl cDNA and not the truncated FFa4short cDNA. Thus in two separate experiments, factor independent 32D sublines emerged which exhibited dramatic overexpression of p140 Axl . Quantitation of Axl expression in both FFa4.1-FI and SV8/4.1-FI cell lines by¯ow cytometry showed approximately 5 ± 9-fold greater Axl expression than seen in the respective axl-transduced but untransformed precursor 32D cell lines ( Figure 6B ), and about 30 ± 60 times the level of p140
Axl as seen in the Axl transformed 3T3 cells ( Figure 6B) . Hence, 32D cell transformation by Axl appears to require constitutive Axl kinase activation which results from very high levels of surface p140 Axl . Receptor crowding has been documented to induce ligand independent dimerization in other RTKs (Kokai et al., 1989; Di Mareo et al., 1990; Taylor et al., 1995) . In support of this as a mechanism of Axl activation, we performed crosslinking experiments on the Axl transformed FFa4.1-FI infected 32D cell line and found a greater amount of the surface Axl to be in a multimeric complex as compared to untransformed 32D wildtype Axl cells (data not shown). Interestingly, the transformation associated pp190 seen in Axl transformed 3T3 cells was not detected in the FFa4.1-FI or SV8/4.1-FI cells (Figure 7) . Taken together, these data suggest that Axl transformation in 3T3 cells is associated with the appearance of pp190, and that in its absence, Axl can transform by dramatic overexpression.
Discussion
In this study, we sought to identify and characterize oncogenic axl mutants that might uncover the structural requirements for Axl regulation. We chose a retroviral approach for the generation of such genetic variants to permit an unbiased selection of transforming mutations. Such an approach was previously used to discover mutations that render the erythropoietin (EPO)-receptor either more sensitive to EPO, or constitutively active (Yoshimura et al., 1990) . The growth factor sensitive EPO-R variant was the result of a C-terminal truncation of 42 amino acids which deleted a terminal tyrosine residue, whereas the factor independence was associated with an arginine to cysteine change at codon 129 in the extracellular domain.
Serial passage of a helper associated recombinant axl retrovirus generated three viral strains with increased transforming capacity. Sequencing of the respective proviruses revealed that they were all clonally related to a precursor virus marked by a silent T to C mutation in base position 1961 and which represents the signature mutation for virus 1B1 ( Figure  8 ). The SV8 strain was further characterized by a second silent G?A mutation at base 1724. One of the axl viral mutants, FFa4short, acquired a truncated Cterminus and displayed a highly transformed phenotype when infected into naive NIH3T3 ®broblasts. That these viruses induced transformation upon passage using comparable viral titers suggests that their transforming potential is an intrinsic property of the individual retroviruses rather than a simple consequence of multiplicity of infection or of insertional activation.
The FFa4 transforming viral strain was found to be a composite of two viruses, one identical to the 1B1 in sequence, and the other (FFa4short) harboring a deletion of 195 base pairs in the 3' end of the axl cDNA that encompasses the TAG stop codon. This deletion results in the truncation of 45 amino acids in the C-terminus of Axl and a read through that adds back 69 amino acids due to the translation of sequences within native 3' UTR. To prove that FFa4short carries an axl cDNA with increased oncogenic potential, we subcloned the truncated axl into pLXSN and subsequently infected the resultant helper free virus into 3T3 indicator cells. Our results con®rm that FFa4short has augmented 3T3 transforming ability. Through a series of deletion mutants, we determined that the increased transforming activity of FFa4short did not result from Axl carboxy-terminal truncation alone but involved the addition of sequences encoded by the 3' UTR. In addition, these transformed cells overexpressed p140
Axl . The presence of an appended carboxy terminus appeared to promote receptor activation and abrogate the need for secondary passaging to induce transformation. Whether this increased transforming ability resulted from higher steady state levels of the Axl protein or a functional dierence of the chimeric receptor is unclear. Possible mechanisms for this augmented transforming ability include enhanced protein stability, altered substrate selection, perturbation of receptor turnover, and altered intramolecular interactions (Kornilova et al., 1996; Lorenzi et al., 1996; O'Connor et al., 1997) . Nevertheless, it remains consistent that transformation by any form of Axl is associated with receptor overexpression.
We furthermore observed that changing the tyrosine at codon 866 to phenylalanine (Y866F) was by itself insucient to render the axl cDNA transforming (Figure 4) . By contrast, studies on other tyrosine kinases have implicated the terminal tyrosine in the negative control of kinase signaling functions (i.e. the insulin receptor, CSF-1 receptor, Src nonreceptor tyrosine kinase; Roussel et al., 1987; Ellis et al., 1986; Thies et al., 1989; Cantley et al., 1991; Herbst et al., 1995; . For example, an insulin receptor mutant lacking C-terminal Tyr1316 and Tyr1322 demonstrates increased insulin induced mitogenesis and mitogen activated protein kinase activity (Ando et al., 1992) . The kinase activity of Src is inhibited by the phosphorylation of the C-terminal Tyr527. Intramolecular binding of the phosphorylated tyrosine to the SH-2 domain of SRC inhibits exogenous substrate interactions and downstream signaling, whereas deletion of this residue leads to constitutive activation (Cooper and King, 1986) . In the case of the EGF receptor, the C-terminal tyrosine residues (i.e. Tyr1173, Tyr1148, Tyr1068) may serve as intrinsic phosphorylation sites that compete with exogenous substrates for binding to the active domain of the receptor. Ligand induced autophosphorylation or deletion of these terminal residues are thought to increase access of exogenous substrates to the receptor, resulting in augmented signaling capacity (Ullrich and Schlessinger, 1990; Honnegger et al., 1988a,b; Bertics et al., 1988; Khazaie et al., 1988; Velu et al., 1989) . In the case of EGFR, progressive C-terminal deletion mutants increased the phosphorylation of non-SH2 containing substrates (eps8 and eps15) which correlates well with enhanced transforming potential of these deletion mutants (Alvarez et al., 1995) . Though conservation of Axl's terminal tyrosine 866 among members of the Axl family of receptor tyrosine kinases (forming the consensus sequence RY(V/I)(L/F)) suggests functional signi®cance to this residue, mutation analysis of this tyrosine did not aect Axl's transforming ability in 3T3 cells. Thus, the exact function of this motif remains unclear.
Other members of the Axl/UFO family of receptor tyrosine kinases can also induce transformation employing dierent structural mechanisms. v-eyk (vryk), the avian retroviral homologue of human c-mer, was discovered as the transduced oncogene in an acutely transforming retrovirus, RPL30, isolated from a variety of chicken mesenchymally derived tumors. v-eyk appears to be transforming through substitution of the extracellular domain of its protooncogene, c-eyk/ mer, with the viral gp37 envelope gene (Jia et al., 1992) . The neural speci®c axl homologue, sky/rse, can transform murine ®broblast cell lines either when overexpressed or when the extracellular domain is deleted, resulting in an activated cytoplasmic version of sky (also called brt) (Taylor et al., 1995; Lai et al., 1994) . Recently, replacement of the axl ECD with viral gag sequences was found to enhance Axl's transforming potential in NIH3T3 cells and suggests that mutations within the receptor ectodomain may increase Axl's transforming activity (Zhang et al., 1996) . None of our transforming retroviruses harbored ectodomain alterations. Moreover, an engineered truncation of the Axl ectodomain using the endogenous Axl initiating methionine did not render Axl , unpublished results) . Thus, N-terminal alterations of Axl appear activating only under speci®c conditions. Our investigations, however, suggest that receptor overexpression and Cterminal alterations identi®ed by a process of retroviral evolutionary selection may be the primary pathways to augment Axl's transforming activity.
Despite the ®nding of a transforming C-terminal mutation, the vast majority of events leading to Axl transformation involve simple overexpression. We have previously described that transfection of axl into 3T3 cells transforms through ampli®cation of the wild-type axl cDNA leading to overexpression (O'Bryan et al., 1991) . In the error-prone retroviral system used here, transformation by two of three viral strains (SV8 and 1B1) was primarily caused by dramatic overexpression of Axl rather than through activating mutations, since both viral sublines transmit the intact axl sequence. Activating promoter mutations of the MoMLV-LTR can account for upregulated gene expression and have also been documented to change the host expression speci®city of the retrovirus (Hanecak et al., 1991) . The possibility that viral infection induced cellular transformation by insertional mutagenesis is unlikely since the acutely transforming nature of the viral strain was carried with each successive viral passage. That both transfection and infection approaches lead almost exclusively to variants overexpressing a normal axl cDNA strongly suggest that overexpression is the simplest and most potent mechanism by which Axl can induce cellular transformation.
This conclusion is supported by our observations in the cell line speci®city of Axl transformation. Our three transforming viral strains were all able to eciently transform 3T3 cells, yet were ineective when applied to 32D and NR6 cells. Tissue speci®city for oncogene transformation has been previously documented. An insertionally activated c-erbB (1Ac-erbB), which consists of gag sequences replacing the c-erbB ectodomain, can transform erythroblasts but not ®broblasts (Carter et al., 1995) . The presence of an unde®ned transformation inhibitory factor in ®broblasts absent in erythroblasts was speculated. Further investigations into verbB variants displaying diverse tissue speci®c patterns of transformation revealed the engagement of speci®c signaling pathways associated with the transformation of dierent tissue types (McManus et al., 1995) . Our data, however, suggest that the tissue or cell line speci®city for Axl transformation may be due to host factors that facilitate p140
Axl tyrosine phosphorylation. In investigating the mechanism of this resistance to transformation, we found that although the levels of p140
Axl expression were equivalent in infected 3T3, NR6 and 32D cells, the inability to transform was correlated with the absence of tyrosine phosphorylation of the transduced Axl ( Figure 5 ): Axl-transformed 3T3 cells (FFa4-3T3, 1B1-3T3, and SW-3T3) all showed ligand independent tyrosine phosphorylation of p140 Axl compared to the absence of phosphorylation in the 32D cell equivalents. Notably, the lack of transforming potential is not a result of inactive viral mutants since viral recovery experiments showed that the resistant 32D and NR6 cells produced axl viruses that could still eciently transform naive NIH3T3 cells. Upon spontaneous transformation, however, the FFa4.1-FI and SV8/FFa4.1-FI 32D cells showed up to a ninefold greater increase in surface Axl expression relative to their infected but untransformed precursor 32D sublines, which in turn express up to sixfold higher p140 Axl levels than the Axl-transformed 3T3 cells (Figure 6b) . Thus, the surface levels of p140 Axl required for NIH3T3 cell transformation are 1/60 ± 1/30 that for 32D cell transformation.
The components mediating a lower threshold for p140
Axl phosphorylation and transformation in 3T3 cells remain unclear. However, the absence of an Axl speci®c phosphatase or a role for the transformation associated pp190 found speci®cally in 3T3 cells may account for the dierences in transforming susceptibility seen between 3T3, 32D and NR6 cells. Taken together, our results suggest that the biological eects of Axl expression are determined by the cellular context, and that extrapolation of expression data and function should be made with caution.
Materials and methods
Generation and infection of replication competent recombinant axl retroviruses
The axl cDNA 6-2 was cloned into the expression vector pLXSN (pLaxlSN) as previously described (Miller and Rosman, 1989; O'Bryan et al., 1991) . Recombinant axl retroviruses were generated by transfection of 10 mg of pLaxlSN into N1H3T3 cells using Lipofectamine (BRL, Grand Island, NY) followed by selection of resistant colonies in G418 (BRL) at 800 mg/ml and subsequent infection of these cells with conditioned media (CM) containing ecotropic MoMLV (kindly provided by Dr J Olsen, UNC-Chapel Hill). Cells were then reseeded and grown to con¯uency. The axl retrovirus containing CM was harvested and ®ltered through a 0.2 mm membrane (Millipore). The viral titer was estimated by infecting parental NIH3T3 cells with serial dilutions of the MoMLV-pLaxlSN supernatant. For infections, cells were seeded at a density of 1610 5 cells per 60 mm plate and incubated for 2 h with 4610 5 ± 1610 6 c.f.u. (colony forming units) of the axl/MoMLV retrovirus-containing CM in the presence of 8 mg/ml Polybrene (Sigma). Twenty-four hours after infection, G418 selection was applied and the culture was observed for focus formation and transformation over a 30 day period. Following selection, CM of the G418 resistant cell lines was harvested, ®ltered and used for the next round of infection of parental 3T3 cells.
Cell culture and cell lines
The murine IL-3 dependent 32D cell lines produced through viral infection with 1B1, FFa4, and SV8 CM, the factor-independent (FI) 32D cells, and the ecotropic murine retroviral packaging cell line GP+E86 were maintained as previously described (McCloskey et al., 1994; Fridell et al., 1996) . Early-passage NIH3T3 fibroblasts and viral-infected NIH3T3 cell lines were cultured in Dulbecco's Modi®cation of Eagle's Medium (DMEM-H) (Gibco, BRL) containing 10% fetal bovine serum and penicillin/streptomycin (Gibco, BRL). NR6 cells were propagated in DMEM-L supplemented with 10% FBS, 1% L-Glutamine and penicillin/streptomycin.
Immunoprecipitation and Western blot analysis
Cells were lysed in lysis buer containing 1% Triton X-100 and protease inhibitors as previously described (McCloskey et al., 1994) . For immunoprecipitation, 350 ± 600 mg of cell lysates were precleared with 5 mg per ml of Immunopure Rabbit Gamma Globulin (Pierce) followed by Protein A/G PLUS-Agarose beads (Santa Cruz) for 1 h at 48C. Precleared lysates were subsequently incubated with a carboxyl terminal antibody raised against the peptide sequence CGADRSPAAPGQEDGA (anti-COOH Axl antibody 17-4; 1 : 1000) or with an anity puri®ed antibody raised against amino acids 33 ± 136 (anti-NH 2 Axl; 1 : 250) overnight at 48C (McCloskey et al., 1994; O'Bryan et al., 1995) . Immune complexes were precipitated by adding 40 mL of Protein A/G PLUS-Agarose beads. Immune complexes were washed with 361 ml lysis buer and sample buer was added to the washed beads. Samples were heat denatured and eluted proteins were loaded on a 9% SDS polyacrylamide gel. Resolved proteins were electrophoretically transferred onto Immobilon-P Transfer Membranes (Millipore). Western blot analysis was performed as previously described (Fridell et al., 1996) with primary antibodies indicated in the ®gure legends.
PCR cloning of proviral DNA, sequence analysis and generation of recombinant axl mutants Genomic DNA (gDNA) was extracted from 6610 6 cells using a Genepure DNA extractor (341 Nucleic Acid Puri®cation System, Applied Biosystems). Each polymerase chain reaction (PCR) consisted of 100 ± 300 ng gDNA as template . For sequencing of FFa4-axl, primer pairs JB3/7-2-3; JB3/JB6; JB5/PJ6; PJA23/PJA3; PJA14/PJA17; PJA18/ PJA20 were used to amplify FFa4-axl proviral cDNA fragments as previously described (O'Bryan et al., 1991) . PCR was carried out in a 50 ml total volume, with 0.025 nmol of each primer, 0.01 mmol dNTPs, 16GeneAmp 106PCR Buer (contains 15 mM MgCl 2 ), and 0.25 ml AmpliTaq DNA Polymerase (Roche, Perkin-Elmer). PCR products were subcloned into TA-cloning vector using TA Cloning Kit (Invitrogen, San Diego, CA) according to the manufacturer's protocol, and sequencing of FFa4-axl plasmid clones was performed using the Sequenase Version 2.0 Kit (USB, Cleveland, OH). Mutant proviral strains FFa4, FFa4short, SV8, 1B1, SV8/4.1-FI and FFa4.1-FI were ampli®ed from gDNA using the Expand Long Template PCR System (Boehringer Mannheim, Indianapolis, IN) with 100 ± 300 ng template gDNA, forward primer EcoJB3 (5'-CGGAATTCAGCCCAGCAACTTCTGAGGA-3') which includes an EcoRI site, and reverse primer 3'pLXSN (5'-GCGGATCCTCGAGTTAACG-3') which anneals 3' to an EcoRI site located in the pLXSN polylinker. PCR products were electrophoretically separated, gel puri®ed, and digested with EcoRI prior to cloning into the EcoRI site of pLXSN. Plasmid sequencing was performed, and suspected mutations were con®rmed using asymmetric PCR from gDNA and sequencing of single stranded products as described elsewhere (Medori et al., 1992) .
Axl mutants axl854 and axl878 were generated by PCR with the Expand Long Template PCR System using pLaxl6-2SN as template with EcoJB3 as the forward primer and axl854
(5'-CGGAATTCGCAGTGAGTCAGCTACAG-GAA-3') and axl878 (5'-CGGAATTCATCAGCAGGCT-TAGCGGGGCTA-3') as reverse primers, respectively. Amplicons were digested with EcoRI and cloned into pLXSN. Axl mutant Y866F was created with the Altered Sites in vitro Mutagenesis System (Promega, Madison, WI) using mutagenesis primer Y866F (5'-GCAGAGGA-CAAAGCGTCCAG-3' and was then cloned into the EcoRI site of pLXSN.
Biologic activity of axl mutants
To con®rm the transforming potential of the viral and recombinant axl mutants, a standard NIH3T3 cell focus formation assay was performed by infecting parental cells with equivalent amounts of titered virus and selecting with G418. The GP+E86 retroviral packaging cell line was used to generate viruses by transfecting with 10 mg of cDNA from pLXSN, pLaxl6-2SN, pLaxl854SN, pLaxl878SN,  pLFFa4shortSN and pLY866HN constructs. CM from these transfected cell lines were then used to infect naive NIH3T3 cells as described above. The extent of transformation in NIH3T3 cells following G418 selection was assessed both by observing the time required to achieve focus formation and by counting the number of foci after a 30 day period. Transformation of 32D cells was determined by withdrawing IL-3 and assessing for factor-independent growth.
Flow cytometry
FACS analysis was performed in a Becton Dickinson
FACScan. An Axl monoclonal antibody (Axl MoAb #9) directed against the ®rst Ig Loop of Axl (Fridell et al., 1996) was used to assay surface Axl expression in virally transduced murine cell lines. The MoAb was directly conjugated to phycoerythrin (PE). For FACS analysis, 800 ng of Axl-PE antibody was mixed with 1610 6 cells and incubated on ice for 20 min. Stained cells were then washed twice with PBS containing 0.1% BSA. The reported value represents the mode of¯uorescence intensity determined using the Cyclops¯ow cytometry software package.
